<DOC>
	<DOC>NCT01644448</DOC>
	<brief_summary>This is a multicentre, open label, randomized, pilot study to evalute safety and efficacy of Human Platelet Lysate (HPL) in subjects with Periorbital Hyperpigmentation. The study is being conducted at 2 centers in India.The primary endpoints are Physicians and Patient Self assessment score. The secondary endpoints are improvement in photographic assessment form randomization to end of study.</brief_summary>
	<brief_title>A Study to Determine the Safety &amp; Efficacy of Autologous Human Platelet Lysate (HPL) in Treatment of Dark Circles</brief_title>
	<detailed_description />
	<mesh_term>Hyperpigmentation</mesh_term>
	<criteria>Subjects (male and female), aged 18 to 55 years (both inclusive) with Periorbital Hyperpigmentation. Subject willing to refrain from any other treatment of Periorbital Hyperpigmentation during entire study duration. Subjects who are willing to give informed consent and adhere to the study protocol. Subjects aged less than 18 and more than 55 years Subjects with history of connective tissue disease. Subjects with metabolic or hematopoietic disorders Subjects unwilling to or unable to comply with the study protocol. Subjects taking concomitant therapy that might interfere with the study results in the investigator's opinion or participating in another trial in the past 30 days.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>